Logo image of NSPR

INSPIREMD INC (NSPR) Stock Fundamental Analysis

USA - NASDAQ:NSPR - US45779A8466 - Common Stock

2.4 USD
-0.04 (-1.44%)
Last: 10/9/2025, 9:30:57 PM
Fundamental Rating

3

Taking everything into account, NSPR scores 3 out of 10 in our fundamental rating. NSPR was compared to 191 industry peers in the Health Care Equipment & Supplies industry. While NSPR seems to be doing ok healthwise, there are quite some concerns on its profitability. NSPR is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

NSPR had negative earnings in the past year.
NSPR had a negative operating cash flow in the past year.
In the past 5 years NSPR always reported negative net income.
NSPR had a negative operating cash flow in each of the past 5 years.
NSPR Yearly Net Income VS EBIT VS OCF VS FCFNSPR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 -10M -20M -30M

1.2 Ratios

NSPR's Return On Assets of -124.11% is on the low side compared to the rest of the industry. NSPR is outperformed by 80.63% of its industry peers.
NSPR's Return On Equity of -204.42% is on the low side compared to the rest of the industry. NSPR is outperformed by 72.77% of its industry peers.
Industry RankSector Rank
ROA -124.11%
ROE -204.42%
ROIC N/A
ROA(3y)-61.73%
ROA(5y)-56.41%
ROE(3y)-81.81%
ROE(5y)-75.32%
ROIC(3y)N/A
ROIC(5y)N/A
NSPR Yearly ROA, ROE, ROICNSPR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200 -200 400 -400 600 800

1.3 Margins

Looking at the Gross Margin, with a value of 21.06%, NSPR is doing worse than 78.53% of the companies in the same industry.
NSPR's Gross Margin has been stable in the last couple of years.
NSPR does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 21.06%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y8.84%
GM growth 5Y1.01%
NSPR Yearly Profit, Operating, Gross MarginsNSPR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -200 -400 -600

More info and screens

6

2. Health

2.1 Basic Checks

NSPR does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for NSPR has been increased compared to 1 year ago.
The number of shares outstanding for NSPR has been increased compared to 5 years ago.
There is no outstanding debt for NSPR. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
NSPR Yearly Shares OutstandingNSPR Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M
NSPR Yearly Total Debt VS Total AssetsNSPR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M

2.2 Solvency

Based on the Altman-Z score of -10.40, we must say that NSPR is in the distress zone and has some risk of bankruptcy.
NSPR's Altman-Z score of -10.40 is on the low side compared to the rest of the industry. NSPR is outperformed by 79.06% of its industry peers.
There is no outstanding debt for NSPR. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -10.4
ROIC/WACCN/A
WACC8.77%
NSPR Yearly LT Debt VS Equity VS FCFNSPR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M

2.3 Liquidity

A Current Ratio of 2.81 indicates that NSPR has no problem at all paying its short term obligations.
NSPR has a Current ratio (2.81) which is in line with its industry peers.
A Quick Ratio of 2.47 indicates that NSPR has no problem at all paying its short term obligations.
NSPR's Quick ratio of 2.47 is fine compared to the rest of the industry. NSPR outperforms 61.26% of its industry peers.
Industry RankSector Rank
Current Ratio 2.81
Quick Ratio 2.47
NSPR Yearly Current Assets VS Current LiabilitesNSPR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M

More info and screens

5

3. Growth

3.1 Past

The earnings per share for NSPR have decreased strongly by -12.16% in the last year.
The Revenue has been growing slightly by 7.60% in the past year.
NSPR shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 13.51% yearly.
EPS 1Y (TTM)-12.16%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-18.18%
Revenue 1Y (TTM)7.6%
Revenue growth 3Y15.92%
Revenue growth 5Y13.51%
Sales Q2Q%2.24%

3.2 Future

The Earnings Per Share is expected to grow by 8.60% on average over the next years. This is quite good.
The Revenue is expected to grow by 74.86% on average over the next years. This is a very strong growth
EPS Next Y-12.46%
EPS Next 2Y1.92%
EPS Next 3Y8.6%
EPS Next 5YN/A
Revenue Next Year7.09%
Revenue Next 2Y47.95%
Revenue Next 3Y74.86%
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
NSPR Yearly Revenue VS EstimatesNSPR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 10M 20M 30M
NSPR Yearly EPS VS EstimatesNSPR Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2019 2020 2021 2022 2023 2024 2025 2026 2027 -1M -2M -3M -4M -5M

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for NSPR. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for NSPR. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
NSPR Price Earnings VS Forward Price EarningsNSPR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
NSPR Per share dataNSPR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.2 -0.2 0.4 -0.4 -0.6 -0.8

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y1.92%
EPS Next 3Y8.6%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for NSPR!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

INSPIREMD INC

NASDAQ:NSPR (10/9/2025, 9:30:57 PM)

2.4

-0.04 (-1.44%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)08-04 2025-08-04/amc
Earnings (Next)11-10 2025-11-10/bmo
Inst Owners35.44%
Inst Owner Change0%
Ins Owners14.39%
Ins Owner Change1.01%
Market Cap100.13M
Analysts82.5
Price Target4.59 (91.25%)
Short Float %0.42%
Short Ratio1.1
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-2.94%
Min EPS beat(2)-7.84%
Max EPS beat(2)1.96%
EPS beat(4)3
Avg EPS beat(4)5.04%
Min EPS beat(4)-7.84%
Max EPS beat(4)21.57%
EPS beat(8)5
Avg EPS beat(8)-0.74%
EPS beat(12)9
Avg EPS beat(12)7.61%
EPS beat(16)13
Avg EPS beat(16)13.26%
Revenue beat(2)2
Avg Revenue beat(2)9.05%
Min Revenue beat(2)3.38%
Max Revenue beat(2)14.71%
Revenue beat(4)4
Avg Revenue beat(4)6.31%
Min Revenue beat(4)1.97%
Max Revenue beat(4)14.71%
Revenue beat(8)7
Avg Revenue beat(8)4.9%
Revenue beat(12)11
Avg Revenue beat(12)5.53%
Revenue beat(16)13
Avg Revenue beat(16)4.09%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)22%
EPS NY rev (1m)0%
EPS NY rev (3m)14.43%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-2.23%
Revenue NY rev (1m)0%
Revenue NY rev (3m)2.5%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 14.17
P/FCF N/A
P/OCF N/A
P/B 4.95
P/tB 4.95
EV/EBITDA N/A
EPS(TTM)-0.83
EYN/A
EPS(NY)-0.75
Fwd EYN/A
FCF(TTM)-0.75
FCFYN/A
OCF(TTM)-0.71
OCFYN/A
SpS0.17
BVpS0.49
TBVpS0.49
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -124.11%
ROE -204.42%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 21.06%
FCFM N/A
ROA(3y)-61.73%
ROA(5y)-56.41%
ROE(3y)-81.81%
ROE(5y)-75.32%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y8.84%
GM growth 5Y1.01%
F-Score3
Asset Turnover0.21
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 483.19%
Cap/Sales 23.59%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.81
Quick Ratio 2.47
Altman-Z -10.4
F-Score3
WACC8.77%
ROIC/WACCN/A
Cap/Depr(3y)304.1%
Cap/Depr(5y)236.96%
Cap/Sales(3y)11.74%
Cap/Sales(5y)9.28%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-12.16%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-18.18%
EPS Next Y-12.46%
EPS Next 2Y1.92%
EPS Next 3Y8.6%
EPS Next 5YN/A
Revenue 1Y (TTM)7.6%
Revenue growth 3Y15.92%
Revenue growth 5Y13.51%
Sales Q2Q%2.24%
Revenue Next Year7.09%
Revenue Next 2Y47.95%
Revenue Next 3Y74.86%
Revenue Next 5YN/A
EBIT growth 1Y-56.02%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-33.93%
EBIT Next 3Y-16.71%
EBIT Next 5YN/A
FCF growth 1Y-85.4%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-79.67%
OCF growth 3YN/A
OCF growth 5YN/A